Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Updated: FDA approves Novavax's Covid vaccine after six-week delay, but for a smaller population
Last month
FDA+
HHS can require approval for drugmakers to apply 340B rebate models, court rules
2 months ago
Law
FDA poses efficacy, safety questions over four cancer drugs ahead of two-day adcomm
2 months ago
FDA+
Amarin calls Hikma's drug label arguments 'idiosyncratic,' urges high court to decline case
2 months ago
Law
Mark Cuban compounder joins Trump's new manufacturing initiative
2 months ago
Manufacturing
BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme
2 months ago
Deals
Updated: Novo Nordisk CEO to step down amid stock decline, timeline for successor unknown
2 months ago
People
RFK Jr. adopts new chikungunya vaccine guidance; other recommendations remain under review
2 months ago
R&D
FDA+
'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure
2 months ago
Manufacturing
Regeneron scores $400M+ jury win in Amgen cholesterol drug spat
2 months ago
Law
Eisai says Leqembi is headed for 'demand expansion phase' in US
2 months ago
New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says
2 months ago
FDA+
Bristol Myers CEO says America’s biopharma pole position is not guaranteed
2 months ago
People
Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege
2 months ago
In Focus
Health Tech
Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate
2 months ago
China
Manufacturing
Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision
2 months ago
FDA+
Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing
2 months ago
Financing
China
RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings
2 months ago
FDA+
RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees
2 months ago
FDA+
Sanofi touts $20B investment in US over five years
2 months ago
Manufacturing
FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer
2 months ago
FDA+
AbbVie doubles down on siRNA with $335M upfront bet on ADARx
2 months ago
Startups
Deals
GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope
2 months ago
Deals
Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B
2 months ago
Deals
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page